Selected Publications
Margaret Stalker, Suzanne Walker, Emily S. Lebow, Evan P. Anderson, Leonid Roshkovan, Sharyn I. Katz, Leslie Litzky, Andrew R. Haas, Sunil Singhal, Corey J. Langer, Keith A. Cengel, Melina Elpi Marmarelis: Brain metastases in patients with pleural mesothelioma receiving dual checkpoint blockade compared to single-agent checkpoint blockade or chemotherapy American Society for Clinical Oncology (ASCO) Annual Meeting, Chicago, Illinois : 2024.
C Hajj, J Lee, LA Boe, B Fregonese, ES Lebow, NA Wijetunga, HG Hubbeling, KR Tringale, ME Freret, BS Imber, J Yahalom: Very Low Dose Radiation Therapy for Indolent Lymphomas: Comparing “Big Boom”(4 Gy x 1) vs.“Boom Boom”(2 Gy x 2) American Society of Hematology (ASH) Annual Meeting, San Diego, California : 2023.
Lebow ES, Pike LRG, Seidman AD, Moss N, Beal K, Yu Y: Symptomatic Necrosis With Antibody-Drug Conjugates and Concurrent Stereotactic Radiotherapy for Brain Metastases JAMA Oncol 9 (12): 1729-1733,2023.
NA Wijetunga, E Lebow, A Chan, J Lee, B Fregonese, C Hajj, G Cedarquist, H Hubbeling, J Ma, R Sarkar, K Tringale, E Joffe, A Dogan, AD Zelenetz, G Salles, BS Imber, J Yahalom: Genetic Alterations in Follicular Lymphoma Predict Response to Very Low Dose Radiotherapy American Society of Hematology (ASH) Annual Meeting, San Diego, California : 2023.
N Ari Wijetunga, Emily Lebow, Alexander Chan, Beatrice Fregonese, Venkatraman Seshan, Carla Hajj, Gustav Cederquist, Harper Hubbeling, Jennifer Ma, Reith R Sarkar, Kathryn Tringale, Pallavi Galera, Erel Joffe, Ahmet Dogan, Hans-Guido Wendel, Andrew D Zelenetz, Gilles Salles, Brandon S Imber, Joachim Yahalom: Genetic Alterations of Follicular Lymphoma Can Predict Response to Very Low Dose Radiotherapy American Society of Hematology (ASH) Annual Meeting, San Diego, California : 2023.
Alessi JV, Price A, Richards AL, Ricciuti B, Wang X, Elkrief A, Pecci F, Di Federico A, Gandhi MM, Lebow ES, Santos PMG, Thor M, Rimner A, Schoenfeld AJ, Chaft JE, Johnson BE, Gomez DR, Awad MM, Shaverdian N.: Multi-institutional analysis of aneuploidy and outcomes to chemoradiation and durvalumab in stage III non-small cell lung cancer J Immunother Cancer 11 (11): e007618,2023.
J Eichholz, B Gaeta, H Walch, L Boe, L Kratochvil, LA Del Balzo, Y Yamada, Y Yu, M Zinovoy, DR Gomez, BS Imber, J Isbell, BT Li, Y Murciano-Goroff, K Arbour, N Schultz, ES Lebow, LRG Pike: The Impact of Co-Alterations on Outcomes after Local Therapy for Patients with KRAS-Mutant Lung Adenocarcinoma Brain Metastases American Society for Radiation Oncology (ASTRO) Annual Meeting, San Diego, CA : 2023.
H Veeraraghavan, J Jiang, J Jee, ES Lebow, JO Deasy, A Rimner, N Shaverdian, H Yu, DR Gomez: AI Serial Image Prediction of Progression-Free Survival (PFS) for Locally Advanced Non-Small Cell Lung Cancer (LA-NSCLC) Patients Treated with Chemoradiation (CRT) and Durvalumab Consolidation American Society for Radiation Oncology (ASTRO) Annual Meeting, San Diego, CA : 2023.
LB Kratochvil, ES Lebow, J Eichholz, D Gelblum, CB Simone, AF Shepherd, AJ Wu, JY Shin, A Rimner, J Isbell, BT Li, N Shaverdian, DR Gomez: Prospective, Cell-Free Circulating Tumor DNA (ctDNA) Profiling in Locally Advanced Lung Cancer Treated with Chemoradiation American Society for Radiation Oncology (ASTRO) Annual Meeting, San Diego, CA : 2023.
Lebow ES, Shaverdian N, Eichholz JE, Kratochvil LB, McCune M, Murciano-Goroff YR, Jee J, Eng J, Chaft JE, Kris MG, Kalashnikova E, Feeney J, Scalise CB, Sudhaman S, Palsuledesai CC, Malhotra M, Krainock M, Sethi H, Aleshin A, Liu MC, Shepherd AF, Wu AJ, Simone CB 2nd, Gelblum DY, Johnson KA, Rudin CM, Gomez DR, Razavi P, Reis-Filho JS, Isbell JM, Li BT, Rimner A: ctDNA-based detection of molecular residual disease in stage I-III non-small cell lung cancer patients treated with definitive radiotherapy Front Oncol 13 : 1253629,2023.
Academic Contact Information
3400 Civic Center Boulevard
2nd Floor West
Philadelphia,
PA
19104
Patient appointments: 800-789-7366